From transforming growth factor-beta signaling to androgen action: identification of Smad3 as an androgen receptor coregulator in prostate cancer cells
about
Identification and characterization of a novel androgen receptor coregulator ARA267-alpha in prostate cancer cellsDACH1 inhibits transforming growth factor-beta signaling through binding Smad4Human checkpoint protein hRad9 functions as a negative coregulator to repress androgen receptor transactivation in prostate cancer cellsCytoplasmic PML function in TGF-beta signallingRole of Smad3 in the hormonal modulation of in vivo wound healing responsesPterostilbene-isothiocyanate conjugate suppresses growth of prostate cancer cells irrespective of androgen receptor statusParathyroid hormone-Smad3 axis exerts anti-apoptotic action and augments anabolic action of transforming growth factor beta in osteoblastsAltered TNSALP expression and phosphate regulation contribute to reduced mineralization in mice lacking androgen receptor.The expression of androgen-responsive genes is up-regulated in the epithelia of benign prostatic hyperplasiaStromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activityMolecular interaction of BMP-4, TGF-beta, and estrogens in lactotrophs: impact on the PRL promoter.Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cellsGene targeting to the stroma of the prostate and bone.Pathway bridge based multiobjective optimization approach for lurking pathway predictionRole of the adjacent stroma cells in prostate cancer development and progression: synergy between TGF-β and IGF signaling.Mullerian-inhibiting substance regulates NF-kappa B signaling in the prostate in vitro and in vivo.The androgen receptor represses transforming growth factor-beta signaling through interaction with Smad3.Differential modulation of androgen receptor-mediated transactivation by Smad3 and tumor suppressor Smad4.Androgen regulates follicle-stimulating hormone beta gene expression in an activin-dependent manner in immortalized gonadotropes.A FoxL in the Smad house: activin regulation of FSH.Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function.APPL suppresses androgen receptor transactivation via potentiating Akt activity.DHT selectively reverses Smad3-mediated/TGF-beta-induced responses through transcriptional down-regulation of Smad3 in prostate epithelial cellsProgesterone receptors, their isoforms and progesterone regulated transcriptionDiabetic kidney disease: impact of puberty.Analysis of candidate genes has proposed the role of y chromosome in human prostate cancer.Two major Smad pathways in TGF-beta superfamily signalling.Structure-based virtual screening and identification of a novel androgen receptor antagonist.Apoptosis evasion: the role of survival pathways in prostate cancer progression and therapeutic resistanceGrowth factor signalling in prostatic growth: significance in tumour development and therapeutic targeting.Androgen receptor inclusions acquire GRP78/BiP to ameliorate androgen-induced protein misfolding stress in embryonic stem cellsTransforming growth factor beta enhances the glucocorticoid response of the mouse mammary tumor virus promoter through Smad and GA-binding proteinsALU repeats in promoters are position-dependent co-response elements (coRE) that enhance or repress transcription by dimeric and monomeric progesterone receptors.Endocrine-immune-paracrine interactions in prostate cells as targeted by phytomedicines.Prostate cancer: the need for biomarkers and new therapeutic targets.Redox-mediated and ionizing-radiation-induced inflammatory mediators in prostate cancer development and treatment.The androgen receptor interacts with multiple regions of the large subunit of general transcription factor TFIIF.Mechanism analysis of colorectal cancer according to the microRNA expression profile.Mining featured biomarkers associated with prostatic carcinoma based on bioinformatics.Dissecting the roles of the androgen receptor in prostate cancer from molecular perspectives.
P2860
Q24291571-FB8F0EFD-32BF-4E81-9EFC-FEF2DBD221F5Q24296908-867F036B-1FE2-4C9A-A5A2-6889CA042E50Q24607572-18C533F3-692A-4C44-89DC-3FBDBB22E0F6Q28281152-DB540175-6A2E-4957-A660-3FAC0D1B0E35Q28506745-E54387EF-0E65-47A3-B483-340F8294D325Q28541923-85449958-395C-4F9C-91E4-9E7D42FF849FQ28573174-BD8125D3-4B1B-4127-989F-F83321EE90F4Q30484858-D4578EB9-1A05-454D-8456-A0F7756173E3Q33493120-B938CF8F-8E00-4D69-A7E3-D60086E7ACBBQ33611142-15C35B9B-8F39-4B89-AF9B-268F15F3A3BDQ33642161-ACB0D05A-843C-4EF2-8605-72554EC65A0FQ33694557-C4AAFF73-BE5E-4650-87BD-52956DCCFA14Q33699188-884B1D68-5CFE-48CA-8F5B-C23EB0CD61E7Q33737827-CEF487CB-6F6D-4C19-B9E3-0E0136CAB5CCQ33892994-F30B789F-6029-441A-B701-7B7CE2E8707FQ33897273-27274C2D-5302-446E-95D3-75D499A6FD0BQ33955967-B21C69D0-F206-47CD-97C3-1EA046B35452Q33961300-C1F877EA-0E9A-4F95-9E2B-58A6EC43BEC7Q34099971-0374177F-FE67-4028-8B8F-6E162D5130F4Q34103660-199374E0-4F11-41A4-925F-2E574EA714AFQ34125103-90B9AA85-FF26-47A2-88F2-2B5C3EBDA496Q34181896-32401E71-C15E-4930-99A1-B46BEB767781Q34197256-29483CA6-47A6-4F7D-93EC-5793425AB462Q34219750-0268B95B-E8E6-4BDA-88ED-5DE60A488615Q34826667-E4521A41-025C-429E-93E7-127724C95306Q35015903-7D12FD47-D742-46D4-B297-A6DCB046F920Q35026971-C15B8229-E7BE-4739-8AF2-270D4A5A0C4DQ36216496-5C16AFA6-81DB-4E78-9DAA-6BCC77BC569CQ36282200-004738A9-AAE5-409F-B4B1-130748CAAFC5Q36390245-52135EA1-36B4-4E02-A779-7A973B613EB4Q36809544-70CA06C8-C97B-4B41-BADB-5CA0B43EEC90Q36954106-7E7C1E41-CEA5-48DF-92A9-31BC7AEA3330Q37244854-42F229BF-AE83-41B8-89C2-9803FA913689Q37376875-86B9FFFA-1FE2-42D3-885F-B350967BCD66Q37476043-841AC7A6-51A1-46F7-8120-8285C3789037Q37606662-3432DDC3-C652-483C-9639-C4F6587B124CQ38363646-FD2122EF-F409-4B2B-B21D-27088604063CQ38442211-0FFA46FF-D2CE-4BCD-B970-E42B3C59D6BDQ38486774-6596D4EF-4D10-4AB2-B3DA-76046E01A38FQ39285589-9569D135-BB63-4AEC-AC67-CF5A321CC4B3
P2860
From transforming growth factor-beta signaling to androgen action: identification of Smad3 as an androgen receptor coregulator in prostate cancer cells
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
From transforming growth facto ...... lator in prostate cancer cells
@ast
From transforming growth facto ...... lator in prostate cancer cells
@en
From transforming growth facto ...... lator in prostate cancer cells
@nl
type
label
From transforming growth facto ...... lator in prostate cancer cells
@ast
From transforming growth facto ...... lator in prostate cancer cells
@en
From transforming growth facto ...... lator in prostate cancer cells
@nl
prefLabel
From transforming growth facto ...... lator in prostate cancer cells
@ast
From transforming growth facto ...... lator in prostate cancer cells
@en
From transforming growth facto ...... lator in prostate cancer cells
@nl
P2093
P2860
P356
P1476
From transforming growth facto ...... lator in prostate cancer cells
@en
P2093
P2860
P304
P356
10.1073/PNAS.061305498
P407
P577
2001-03-06T00:00:00Z